Dr. Hirano from Screening Business Unit will give an oral presentation at the symposium of the 99th Annual Meeting of the Japanese Pharmacological Society
Dr. Hirano from the Screening Business Unit, will …
Dr. Takakuwa from Pharmacology Business Unit to present a poster at the 99th Annual Meeting of the Japanese Pharmacological Society
Dr. Takakuwa from the Pharmacology Business Unit, will …
Dr. Murakami from Pharmacology BU to present at the symposium of the 99th Annual Meeting of the Japanese Pharmacological Society
Dr. Murakami from the Pharmacology Business Unit, will …
Researcher Hitaka of the Pharmacology Business Unit will present a poster at the 99th Annual Meeting of the Japanese Pharmacological Society
Researcher Hitaka from the Pharmacology Business Unit, will …
Implementation of nonclinical C-QTc analysis: Demonstration of clinically relevant detection sensitivity with ICH E14/S7B Q&A
The 17th Annual Meeting of Japanese Safety Pharmacology Society
Applicability of Ca transient measurements in cardiotoxicity screening
The 17th Annual Meeting of Japanese Safety Pharmacology Society
A paper by researcher Hitaka of the Pharmacology Business Unit has been published in the International Journal of Obesity.
Efficacy of GLP-1 analog peptides, semaglutide, tirzepatide, and …
Efficacy of GLP-1 analog peptides, semaglutide, tirzepatide, and retatrutide on MC4R deficient obesity and their comparison
International Journal of Obesity